A Meta-Analysis of the Short- And Long-Term Results of Randomized Controlled Trials That Compared Laparoscopy-Assisted and Open Colectomy for Colon Cancer

Purpose: We conducted a meta-analysis to evaluate and compare the short- and long-term results of laparoscopy-assisted colectomy (LAC) and open colectomy (OC) for colon cancer

Clinical significance of the expression of connexin26 in colorectal cancer

<p>Abstract</p> <p>Background</p> <p>Connexin26 (Cx26) is one of the connexins (Cxs) family members which form gap junction channels. Cx26 is considered to be a tumor suppressor gene. However, recent studies revealed that over expression of Cx26 is associated with a poor prognosis in several human cancers. This study investigated the correlation between Cx26 expression and the clinicopathological features and P53 expression in colorectal cancer.</p> <p>Methods</p> <p>One hundred and fifty-three patients who underwent a curative resection were studied. Tissue samples were investigated by immunohistochemical staining using antibodies for Cx26 and P53. Moreover, apoptotic cells were detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) staining.</p> <p>Results</p> <p>Cx26 expression was found in 83 cases (54.2%) and P53 expression in 71 cases (46.4%). A correlation was observed between the Cx26 expression and recurrence, histology, and p53 expression (P < 0.05). Cx26 positive tumors had significantly longer survival than Cx26 negative tumors (P < 0.05). A multivariate Cox analysis demonstrated that Cx26 expression was an independent prognostic factor (P < 0.05). However, no significant correlation was observed between Cx26 and AI.</p> <p>Conclusion</p> <p>This study suggests that Cx26 expression is an independent prognostic factor in patients that undergo a curative resection of colorectal cancer.</p

Fibroblasts growth factor and nerve fragments effect on tibial nerve regeneration in rats: a comparative study

OBJECTIVE: To quantitatively compare rats' tibial nerve regeneration stimulation by Fibroblast Growth Factor (FGF) and nerve fragments using silicone tubes. METHODS: 18 Wistar rats were employed in this experiment. The experimental surgery consisted of resection of an 8-mm tibial nerve segment, followed by an interposition of silicone tubes. On the right side, the tube was filled with a Fibroblast Growth Factor (FGF) solution, and on the left side, it was filled with 1 mm nerve segments. After three months, the animals were submitted to an additional surgery for exposing tibial nerves to the neuronal marker Fluoro-Gold®. After 48 hours, they were perfused with a paraformaldehyde solution and the medullar segment between L3 and S1 was removed and cut into 40 mum-thick segments. RESULTS AND CONCLUSION: The results of neuronal counts showed a higher amount of neurons on the side where FGF was used compared to the side where nervous fragments were placed, suggesting a superior performance of the fibroblast growth factor over nerve fragments for stimulating nervous regeneration in silicone tubes.OBJETIVO: Comparar quantitativamente, a estimulação da regeneração do nervo tibial de ratos pelo Fator de Crescimento de Fibroblastos e por fragmentos de nervo dentro tubos de silicone. MÉTODOS: Foram utilizados 18 ratos da raça Wistar. A cirurgia consistiu inicialmente na ressecção de um segmento de 8 mm do nervo tibial, seguida da interposição com tubos de silicone. No lado direito, o tubo foi preenchido com solução de Fator de Crescimento de Fibroblastos (FGF) e, no lado esquerdo, com segmentos do nervo cortados em fragmentos de 1 mm. Após três meses, os animais foram submetidos a nova cirurgia para exposição dos nervos tibiais ao marcador neuronal Fluro-Gold®. Quarenta e oito horas após a exposição ao corante, os ratos foram perfundidos com solução de paraformaldeído e o segmento medular entre L3 e S1 foi removido e cortado em fatias de 40 micrômetros de espessura. RESULTADOS E CONCLUSÃO: os resultados da contagem neuronal mostraram maior quantidade de neurônios no lado onde foi colocado FGF em relação ao lado onde foram colocados fragmentos nervosos, demonstrando que o fator de crescimento de fibroblastos é superior a fragmentos de nervos na estimulação da regeneração nervosa quando colocados no tubo de silicone.UNIFESPUNIFESP Departamento de Ortopedia e TraumatologiaUNIFESP, Depto. de Ortopedia e TraumatologiaSciEL

Development and scale-up of perfusion cell culture process for higer productivity

Please click Additional Files below to see the full abstract

Significance of adrenomedullin under cardiopulmonary bypass in children during surgery for congenital heart disease.

To elucidate the effect of adrenomedullin (AM) on fluid homeostasis under cardiopulmonary bypass (CPB), we investigated the serial changes in plasma AM and other parameters related to fluid homeostasis in 13 children (average age, 28.2 months) with congenital heart disease during cardiac surgery under CPB. Arterial blood and urine samples were collected just after initiation of anesthesia, just before commencement of CPB, 10 min before the end of CPB, 60 min after CPB, and 24 h after operation. Plasma AM levels increased significantly 10 min before the end of CPB and decreased 24 h after operation. Urine volume increased transiently during CPB, which paralleled changes in AM. Simple regression analysis showed that plasma AM level correlated significantly with urinary vasopressin, urine volume, urinary sodium excretion, and plasma osmolarity. Stepwise regression analysis indicated that urine volume was the most significant determinant of plasma AM levels. Percent rise in AM during CPB relative to control period correlated with that of plasma brain natriuretic peptide (r = 0.57, P &#60; 0.01). Our results suggest that AM plays an important role in fluid homeostasis under CPB in cooperation with other hormones involved in fluid homeostasis.</p

Two Cases of Long-Term Control of Metastatic Colorectal Cancer via FTD/TPI plus Bevacizumab in Elderly Patients

With advances in new cytotoxic drugs and molecular-targeted drugs, the prognosis of patients with metastatic colorectal cancer (mCRC) has improved. However, physicians often hesitate to administer intensive standard regimens to elderly patients with mCRC. Recently, first-line regimens that are effective in and well-tolerated by patients who are not eligible for intensive chemotherapy have been established. However, the therapeutic strategies to adopt after the failure of first-line treatment for patients who are not eligible for intensive chemotherapy remain unclear. We herein report two cases of long-term control of mCRC via FTD/TPI+bevacizumab (Bmab) as second- or third-line treatment in elderly patients without severe adverse events. In case 1, first-line treatment with Tegafur-Uracil, which is a prodrug of 5-FU, caused disease progression in a short period after the initiation of chemotherapy. In case 2, intensive first-line treatment caused severe adverse events, and treatment was discontinued. However, in both cases, disease control was obtained for a long time without severe adverse events by subsequent treatment with FTD/TPI+Bmab. The success in these present cases indicates that FTD/TPI+Bmab as a second- or third-line treatment is a therapeutic option for elderly patients with mCRC who are not eligible for intensive chemotherapy, even after failure of treatment with 5-FU

Complete Response of Pulmonary Metastases from Rectal Cancer to Tegafur-Uracil/Leucovorin plus Bevacizumab in an Elderly Patient: A Case Report

As a result of recent major advances in chemotherapy for metastatic colorectal cancer, the prognosis for patients with metastatic colorectal cancer has improved. However, elderly patients often cannot receive intensive therapy. There are still many problems to solve regarding treatment for elderly patients with metastatic colorectal cancer. We herein report a case of complete response of pulmonary metastases from rectal cancer to tegafur-uracil (UFT)/leucovorin (LV) + bevacizumab (Bmab) in an elderly patient. An 80-year-old woman who had undergone curative surgery for rectal cancer 5 years ago was diagnosed with pulmonary metastases. Taking into account her advanced age and low renal function (creatinine clearance: 41.2 mL/min), UFT/LV + Bmab therapy was selected. The patient received UFT (300 mg/m2/day) and LV (75 mg/day) on days 1–5, 8–12, and 15–19 and Bmab (7.5 mg/kg) on day 1. The treatment cycle was repeated every 21 days. Following 17 courses of treatment without adverse events, a complete response was observed. Furthermore, there was no recurrence within 6 months after the final course of therapy. This case indicates that UFT/LV + Bmab is suitable for the treatment of elderly patients with metastatic colorectal cancer